Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Perspective Therapeutics, Inc.CATX · Entity 694 | COO & VP of HR | June 12, 2023 | June 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Perspective Therapeutics, Inc.
Report date June 12, 2023 · Filed June 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.55 · Expires 2033-06-12 | Direct | 1,722,500 |
Reported balance
After 2023-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-12 · Grant · Acquired 500,000 · Balance 1,722,500 F1: 25% vested as of 6/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 6/12/2024, until fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% vested as of 6/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 6/12/2024, until fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2023 Filed Jun 14, 2023 20:47 UTC | Perspective Therapeutics, Inc. CATX · Entity 694 | GrantStock Options (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001437749-23-017424 · rdgdoc.xml · derivative · entry 1 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,722,500 Underlying: Common Stock · 500,000 shares Expires 2033-06-12 F1 · derivative.exercise_date: 25% vested as of 6/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 6/12/2024, until fully vested. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 22:26 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Exercise / conversionStock Options (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001437749-22-021066 · rdgdoc.xml · derivative · entry 2 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2029-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022. F1 · shares: 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022. F1 · derivative.exercise_date: 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022. F1 · derivative.underlying_shares: 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 22:26 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Exercise / conversionCommon Stock | 50,000 | $0.43 | $21,500.00 |
DisclosureSEC source: 0001437749-22-021066 · rdgdoc.xml · nonDerivative · entry 1 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2022 Filed Sep 22, 2022 21:05 UTC Amendment | Perspective Therapeutics, Inc. ISR · Entity 694 | Exercise / conversionStock Options (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001437749-22-022927 · rdgdoc.xml · derivative · entry 2 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2029-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022. F1 · shares: 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022. F1 · derivative.exercise_date: 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022. F1 · derivative.underlying_shares: 150,000 stock options were granted on 6/18/2019. 25% vested on 6/18/2019, 25% vested on 6/18/2020, 25% vested on 6/18/2021 and the remaining 25% vested on 6/18/2022. Read SEC document |
| August 18, 2022 Filed Sep 22, 2022 21:05 UTC Amendment | Perspective Therapeutics, Inc. ISR · Entity 694 | Exercise / conversionCommon Stock | 50,000 | $0.43 | $21,500.00 |
DisclosureSEC source: 0001437749-22-022927 · rdgdoc.xml · nonDerivative · entry 1 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: The previous Form 4 incorrectly stated 87,940 shares owned, but should have stated 77,940 shares owned. Read SEC document |
| August 05, 2022 Filed Aug 11, 2022 00:14 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Exercise / conversionStock Options (right to buy) · Derivative | 22,500 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001437749-22-019882 · rdgdoc.xml · derivative · entry 2 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 452,500 shares Expires 2032-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: 475,000 stock options were granted on 7/21/2022. 25% vested on 7/21/2022 and the remaining 75% will vest over the next three (3) years, commencing on 7/21/2022, until fully vested. The shares exercised on 8/5/2022 represent the shares that vested on 7/21/2022. F1 · shares: 475,000 stock options were granted on 7/21/2022. 25% vested on 7/21/2022 and the remaining 75% will vest over the next three (3) years, commencing on 7/21/2022, until fully vested. The shares exercised on 8/5/2022 represent the shares that vested on 7/21/2022. F1 · derivative.exercise_date: 475,000 stock options were granted on 7/21/2022. 25% vested on 7/21/2022 and the remaining 75% will vest over the next three (3) years, commencing on 7/21/2022, until fully vested. The shares exercised on 8/5/2022 represent the shares that vested on 7/21/2022. F1 · derivative.underlying_shares: 475,000 stock options were granted on 7/21/2022. 25% vested on 7/21/2022 and the remaining 75% will vest over the next three (3) years, commencing on 7/21/2022, until fully vested. The shares exercised on 8/5/2022 represent the shares that vested on 7/21/2022. Read SEC document |
| August 05, 2022 Filed Aug 11, 2022 00:14 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Exercise / conversionCommon Stock | 22,500 | $0.33 | $7,425.00 |
DisclosureSEC source: 0001437749-22-019882 · rdgdoc.xml · nonDerivative · entry 1 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2022 Filed Jul 28, 2022 21:20 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | GrantStock Options (right to buy) · Derivative | 475,000 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001437749-22-018030 · rdgdoc.xml · derivative · entry 1 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,295,000 Underlying: Common Stock · 475,000 shares Expires 2032-07-21 F1 · derivative.exercise_date: 25% vested as of 7/21/2022, and the remaining 75% will vest over the next three (3) years, commencing on 7/21/2023, until fully vested. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:28 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | GrantStock Options (right to buy) · Derivative | 320,000 | $0.00 Strike: $0.79 | $0.00 |
DisclosureSEC source: 0001437749-21-016451 · rdgdoc.xml · derivative · entry 1 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 820,000 Underlying: Common Stock · 320,000 shares Expires 2031-07-01 F1 · derivative.exercise_date: 25% vested as of 7/1/2021, and the remaining 75% will vest over the next three (3) years, commencing on 7/1/2022, until fully vested. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:44 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | GrantStock Options (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001437749-20-013876 · rdgdoc.xml · derivative · entry 1 Streeter Jennifer · CIK 0001709780 · COO & VP of HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 150,000 shares Expires 2030-06-23 F1 · derivative.exercise_date: 25% vested as of 6/23/2020, and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested. Read SEC document |
| June 18, 2019 Filed Jun 24, 2019 20:57 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | GrantStock Options (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001437749-19-012557 · rdgdoc.xml · derivative · entry 1 Streeter Jennifer · CIK 0001709780 · VP of Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 150,000 shares Expires 2029-06-18 F1 · derivative.exercise_date: 25% vested as of 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested. Read SEC document |
| June 13, 2018 Filed Jun 20, 2018 00:24 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | GrantStock Options (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001437749-18-012093 · rdgdoc.xml · derivative · entry 1 Streeter Jennifer · CIK 0001709780 · VP of Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 100,000 shares Expires 2028-06-13 F1 · derivative.exercise_date: 25% vested as of 6/13/2018, and the remaining 75% will vest over the next three (3) years, commencing on 6/13/2019, until fully vested. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 20:47 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | GrantStock Options (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001642247-17-000008 · primary_doc.xml · derivative · entry 3 Streeter Jennifer · CIK 0001709780 · VP of Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2027-06-27 F1 · security: The three reported transactions involved a grant of the "old" option, a termination of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a new option. F2 · derivative.exercise_date: 25% vested as of 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested. Read SEC document |
| June 15, 2017 Filed Jun 29, 2017 20:47 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Disposition to issuerStock Options (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001642247-17-000008 · primary_doc.xml · derivative · entry 2 Streeter Jennifer · CIK 0001709780 · VP of Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2026-07-11 F1 · security: The three reported transactions involved a grant of the "old" option, a termination of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a new option. F1 · derivative.exercise_date: The three reported transactions involved a grant of the "old" option, a termination of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a new option. Read SEC document |
| July 11, 2016 Filed Jun 29, 2017 20:47 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | GrantStock Options (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001642247-17-000008 · primary_doc.xml · derivative · entry 1 Streeter Jennifer · CIK 0001709780 · VP of Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2026-07-11 F1 · security: The three reported transactions involved a grant of the "old" option, a termination of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a new option. F1 · derivative.exercise_date: The three reported transactions involved a grant of the "old" option, a termination of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a new option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.